Search filters

List of works by Luigi Aurisicchio

Activation of an early feedback survival loop involving phospho-ErbB3 is a general response of melanoma cells to RAF/MEK inhibition and is abrogated by anti-ErbB3 antibodies.

scientific article published on 27 July 2013

Activation of the ErbB3-AKT axis promotes melanoma cell survival and proliferation in response to RAF/MEK inhibition.

scientific article published on 6 May 2014

Combination of antibodies directed against different ErbB3 surface epitopes prevents the establishment of resistance to BRAF/MEK inhibitors in melanoma.

scientific article published on 7 July 2015

ErbB3 plays a key role in the early phase of establishment of resistance to BRAF and/or MEK inhibitors

scientific article

Identification of the Thyroid Transcription Factor-1 as a Target for Rat MST2 Kinase

scientific article published on January 16, 1998

Melanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015

scientific article

New developments in cancer vaccines

scientific article published in October 2013

Novel metronomic chemotherapy and cancer vaccine combinatorial strategy for hepatocellular carcinoma in a mouse model

scientific article

Tel-eVax: a genetic vaccine targeting telomerase for treatment of canine lymphoma

scientific article published on 11 December 2018

The natural compound fucoidan from New Zealand Undaria pinnatifida synergizes with the ERBB inhibitor lapatinib enhancing melanoma growth inhibition

scientific article published on 2 January 2017

The perfect personalized cancer therapy: cancer vaccines against neoantigens.

scientific article published on 20 April 2018

The promise of anti-ErbB3 monoclonals as new cancer therapeutics

scientific article published on August 1, 2012